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hibition of late sodium current (INa, L) in a 2.5 year-old Chinese girl
with the typical TS phenotype of syndactyly, QT prolongation, 2:1 AV
block (AVB) and T wave alternans (TWA) in 2012. This study aimed to
review our practices over the past three years and promote the current
therapeutic strategies in the TS management.
METHODS Mexiletine (12.5 mg/kg per day) was initiated when the
proband’s 12-lead ECG revealed QTc of 600 ms, 2:1 AVB and TWA. 12-
lead ECGs and Holter monitoring were obtained once per month
during the ﬁrst year. Afterwards, Holter monitoring was performed
once in every 3-4 months. The QT interval was measured on lead II or
V5. Heart rate–corrected QT (QTc) was calculated using Bazett formula
(QT/ORR). The QT/RR slope was calculated based on the Holter
results.
RESULTS During the ﬁrst two years of treatment of mexiletine at a
maintenance dose of 150 to 200 mg daily, her ECGs and the Holter
monitoring revealed no 2:1 AVB and TWA, blunted QT/RR relationship
and QTc in a range from 500 to 560 ms. During this period, the patient
successfully underwent two syndactyly repair surgeries although the
anesthesiologist reported occurrence of one episode of non-sustained
polymorphic ventricular tachycardia during her second operation. In
the past one year, this patient had two episodes of syncope or
“seizure” activities. In one longer episode, she happened to wear a
Holter which did not reveal any ventricular arrhythmias. Although
they were not correlated to her syncope, 2:1 AVB and TWA reap-
peared. Her mexiletine dose was then adjusted to 250 mg daily. Dose
increase in mexiletine abolished 2:1 AVB and TWA.
CONCLUSIONS Our experiences suggests that inhibition of INa, L by
mexiletineis a promising pharmacotherapeutic approach in reduction
of arrhythmic risks in TS. However, mexiletine appears to lose its
efﬁcacy slowly with time.
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OBJECTIVES Three validated HAS-BLED, HEMORR2HAGES and
ATRIA bleeding scores, or even the CHADS2 and CHA2DS2-VASc stroke
scores, could be used to evaluate atrial ﬁbrillation(AF) patients’ major
bleeding risk. These scores have been validated in the various inde-
pendent studies. We therefore compared the diagnostic accuracy of
the HAS-BLED score to that of other risk scores in anticoagulated
patients with AF.
METHODS We systematically searched the Cochrane Library, Med-
line, PubMed and Embase databases for studies of the comparative
diagnostic performance between the HAS-BLED score and any of the
HEMORR2HAGES, ATRIA, CHADS2 or CHA2DS2-VASc scores. Data were
extracted from applicable studies, and then analyzed using statistical
methods such as the discrimination, calibration, net reclassiﬁcation
improvement(NRI) and integrated discrimination improvement(IDI)
analysis. The primary endpoints of AF patients were also deﬁned
dichotomously and compared between scores <3 and 3 for the HAS-
BLED score.
RESULTS 11 studies were identiﬁed for meta-analysis. We performed
the discrimination analysis by means of C-statistic with 95%
conﬁdence interval(CI). The pooled C-statistics respectively are
0.65(0.61-0.69) for HAS-BLED, 0.63(0.61-0.66) for HEMORR2HAGES,
0.63(0.56-0.72) for ATRIA, 0.55(0.49-0.61) for CHADS2 and 0.56(0.53-
0.59) for CHA2DS2-VASc. The HAS-BLED score demonstrates no sig-
niﬁcant differences of C-statistic for major bleeding risk prediction
when compared to the ATRIA or HEMORR2HAGES bleeding scores, but
gets the opposite results when compared to the CHADS2 or CHA2DS2-
VASc stroke scores. These results are further supported by the sig-
niﬁcant positive NRI and IDI values. Calibration analysis indicates the
HAS-BLED score over-predicts the risk of bleeding in the low
(RR¼1.16,95%CI 0.63-2.13;P¼0.64) risk stratiﬁcation, but under-pre-
dicts the risk of bleeding in the moderate (RR¼0.66,95%CI 0.51-
0.86;P¼0.002) and high (RR¼0.88,95%CI 0.70-1.10; P¼0.27) risk
stratiﬁcations. There are no signiﬁcant differences between the pre-
dicted and the observed major bleeding events in the low and high
risk stratiﬁcations. With regard to the occurrence of major bleeding
events individually, patients with HAS-BLED scores 3 have a greater
risk of major bleeding(RR¼2.97,95%CI, 2.32–3.80;P<0.00001) than
patients with HAS-BLED scores <3. A chi-squared test for trend showsan increasing trend in the occurrence of major bleeding events across
three risk stratiﬁcations according to the HAS-BLED score(c2¼108.57,
Ptrend<0.001).
CONCLUSIONS The HAS-BLED score not only performs better than
the HEMORR2HAGES and ATRIA bleeding scores, but also is superior
to the CHADS2and CHA2DS2-VASc stroke scores for bleeding predic-
tion. The HAS-BLED score should be the optimal choice to assess
major bleeding risk in clinical practice.
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OBJECTIVES An elevated left atrial pressure (LAP), a sign of atrial
structural remodeling, has been reported as a mechanism of atrial
ﬁbrillation (AF). However, the effect of LAP on the recurrence after AF
catheter ablation has not been well elucidated. We aimed to address
the predictive value of LAP and observe the inﬂuence for prognosis.
METHODS 150 patients of AF who underwent a ﬁrst-time catheter
ablation in our hospital were enrolled in the present study. Including
paroxysmal AF (n¼66) and persistent AF (n¼84). All patients under-
went transseptal puncture during procedure. LAP were measured
during sinus rhythm. According to the values of LAP, the patients
were divided into each two groups, high LAP ofparoxysmal AF group
(HP-PAF) and low LAP of paroxysmal AF group (LP-PAF), high LAP of
persistent AF group (HP-PeAF) and low LAP of persistent AF group
(LP-PeAF). The relationship between LAP and clinical variables were
analyzed. Recurrence rates of the each two groups were evaluated
through follow-up. Cox-regression analysis was implemented to ﬁnd
out the independent determinants of AF/AT recurrence after FRCA.
RESULTS (1) 150 AF patients were successfully followed up in the
study. Following up (10.24.9) months, 17 patients (51.5%) in HP-PAF
group and 29 patients (87.9%) in LP-PAF group maintained sinus after
RFCA (P<0.01). 15 patients (33.3%) in HP-PeAF group and 33 patients
(84.6%) in LP-PeAF group maintained sinus rhythm after RFCA
(P<0.01).
(2) For paroxysmal AF, LVEF (linear regression coefﬁcient B¼-0.761,
P¼0.002) was a good noninvasive parameter independently associ-
ated with LAP. For persistent AF, duration of AF(B¼0.826, P<0.001),
CHADS2-VASc score(B¼2.327, P<0.001), LAVI(B¼0.424, P<0.001 ),
IVS(B¼2.847, P<0.001), E/e’ (B¼-3.330, P<0.001), LVEF(B¼-0.651,
P<0.001) were good noninvasive parameters independently associ-
ated with LAP-PeAF.
(3) For paroxysmal AF, Cox-regression analysis revealed that LAP
(OR 1.27; 95%CI: 1.11-1.45; P<0.01) was the independent predictor of
AF/AT recurrence after FRCA. The area under ROC curve of LAP was
0.626. The cutoff point was 16.75mmHg (sensitivity 76.2%, speciﬁcity
82.2%). For persistent AF, LAP (OR 1.56;95%CI: 1.11-1.82; P¼0.019) was
also the independent predictor of AF/AT recurrence after FRCA. The
area under ROC curve of LAP was 0.836. The cutoff points were
17.3mmHg (sensitivity 83.3%, speciﬁcity 88.9%). In addition, duration
of AF, the antero-posterioratrial diameter of left atrium and LVEF
were also the independent predictors of AF/AT recurrence after FRCA.
And the predictive value of LAP was higher than that of others.
CONCLUSIONS (1) Elevated LAP was closely associated with
anatomical remodeling of the left atrium and was an independent
predictor for clinical recurrence after AF ablation.
(2) For paroxysmal AF, LVEF was a good noninvasive parameter
independently associated with LAP. For persistent AF, duration of AF,
CHADS2-VASc score, LAVI, IVS E/e’, LVEF were good noninvasive
parameters independently associated with LAP-PeAF.
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OBJECTIVES We will analyze the coronary venous system anatomy
through coronary vein direct enhancement and inverse develop-
ment. The conclusion will be used to conﬁrm electrophysiological
examination, radio frequency ablation, implantation of a LV lead and
so on.
